These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17851195)

  • 1. Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: insights into the progression of this dementing disorder.
    Butterfield DA; Sultana R
    J Alzheimers Dis; 2007 Aug; 12(1):61-72. PubMed ID: 17851195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.
    Butterfield DA; Boyd-Kimball D
    J Neurochem; 2019 Nov; 151(4):459-487. PubMed ID: 30216447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.
    Sultana R; Perluigi M; Butterfield DA
    Acta Neuropathol; 2009 Jul; 118(1):131-50. PubMed ID: 19288120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.
    Butterfield DA; Reed T; Newman SF; Sultana R
    Free Radic Biol Med; 2007 Sep; 43(5):658-77. PubMed ID: 17664130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.
    Sultana R; Butterfield DA
    J Bioenerg Biomembr; 2009 Oct; 41(5):441-6. PubMed ID: 19777328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics.
    Sultana R; Perluigi M; Butterfield DA
    Antioxid Redox Signal; 2006; 8(11-12):2021-37. PubMed ID: 17034347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics.
    Butterfield DA; Perluigi M; Sultana R
    Eur J Pharmacol; 2006 Sep; 545(1):39-50. PubMed ID: 16860790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative modification of brain proteins in Alzheimer's disease: perspective on future studies based on results of redox proteomics studies.
    Sultana R; Butterfield DA
    J Alzheimers Dis; 2013; 33 Suppl 1():S243-51. PubMed ID: 22683528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42).
    Sultana R; Perluigi M; Butterfield DA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 833(1):3-11. PubMed ID: 16236561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress in Alzheimer disease and mild cognitive impairment: evidence from human data provided by redox proteomics.
    Swomley AM; Butterfield DA
    Arch Toxicol; 2015 Oct; 89(10):1669-80. PubMed ID: 26126631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.
    Reed TT; Pierce WM; Markesbery WR; Butterfield DA
    Brain Res; 2009 Jun; 1274():66-76. PubMed ID: 19374891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain.
    Butterfield DA
    Brain Res; 2004 Mar; 1000(1-2):1-7. PubMed ID: 15053946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.
    Butterfield DA
    Free Radic Biol Med; 2014 Sep; 74():157-74. PubMed ID: 24996204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI.
    Aluise CD; Robinson RA; Cai J; Pierce WM; Markesbery WR; Butterfield DA
    J Alzheimers Dis; 2011; 23(2):257-69. PubMed ID: 20930294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression.
    Butterfield DA; Swomley AM; Sultana R
    Antioxid Redox Signal; 2013 Sep; 19(8):823-35. PubMed ID: 23249141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.
    Butterfield DA; Poon HF; St Clair D; Keller JN; Pierce WM; Klein JB; Markesbery WR
    Neurobiol Dis; 2006 May; 22(2):223-32. PubMed ID: 16466929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease.
    Sultana R; Banks WA; Butterfield DA
    J Neurosci Res; 2010 Feb; 88(3):469-77. PubMed ID: 19774677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox proteomics identification of specifically carbonylated proteins in the hippocampi of triple transgenic Alzheimer's disease mice at its earliest pathological stage.
    Shen L; Chen C; Yang A; Chen Y; Liu Q; Ni J
    J Proteomics; 2015 Jun; 123():101-13. PubMed ID: 25890254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
    Butterfield DA
    Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.